Speaker
Dr
Hans-Petter Hersleth
(Department of Molecular Biosciences, University of Oslo, P.O.Box 1041 Blindern, 0316 Oslo, Norway)
Description
To be able to correctly interpret the crystal structure of redox- and metalloproteins caution must be employed. The influence of X-ray radiation damage to protein crystals is well known to occur even at cryogenic temperatures, and redox active sites like metal sites seem especially vulnerable for radiation-induced reduction [1,2,3]. We have used in situ (online) UV-vis and Raman spectroscopy to study how different haem and flavoproteins are influenced by X-rays during crystallographic data collection [1,2]. The spectroscopic changes have been monitored as a function of X-ray exposure (dose absorbed), Our studies show that these redox states are very fast reduced by X-rays resulting in very short lifedoses. Structurally we have observed for haem proteins a lengthening of the Fe-O bond, and for flavoproteins a bending of the flavin ring during X-ray induced radiation damage, in agreement with DFT [1,2,3]. We have recently started to investigate if varying the doserates and wavelengths can increase the lifedoses. In general our studies show the need of combining protein crystallography with in situ single-crystal spectroscopy when redox and metalloproteins are studied.
[1] H.-P. Hersleth, K.K. Andersson, Biochim. Biophys. Acta 2011: 1814, 785
[2] Å.K. Røhr, et al., Angew. Chem. Int. Ed. 2010, 49, 2324
[3] H.-P. Hersleth et al. Chem. Biodiv. 2008, 5, 2067
Financial support: Norwegian Research Council through projects 214239/F20 / 218412/F50 / 138370/V30 / 216625/F50.
Primary author
Dr
Hans-Petter Hersleth
(Department of Molecular Biosciences, University of Oslo, P.O.Box 1041 Blindern, 0316 Oslo, Norway)
Co-authors
Dr
Guillaume Pompidor
(Swiss Light Source, Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland)
Prof.
K. Kristoffer Andersson
(Department of Molecular Biosciences, University of Oslo, P.O.Box 1041 Blindern, 0316 Oslo, Norway)
Ms
Marie Lofstad
(Department of Molecular Biosciences, University of Oslo, P.O.Box 1041 Blindern, 0316 Oslo, Norway)
Dr
Wouter van Beek
(Swiss–Norwegian Beamlines at ESRF, BP 220, 38043 Grenoble Cedex, France)
Dr
Åsmund K. Røhr
(Department of Molecular Biosciences, University of Oslo, P.O.Box 1041 Blindern, 0316 Oslo, Norway)